Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.

Source:http://linkedlifedata.com/resource/pubmed/id/7585637

Cancer Res. 1995 Dec 1 55 23 5574-9

Download in:

View as

General Info

PMID
7585637